AnalystsMatthew KellerMatthew Keller's Stock Forecasts
AnalystsMatthew Keller
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4738 out of 5163 analysts
Average Return
-25.21%
Win Rate
18%2 out of 11
Risk vs Reward
Poor
Good
Matthew Keller Analyst Color
Get additional color on Matthew Keller's coverage of popular stocks
Matthew Keller's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inflarx NvIFRX | 2 | Buy | $6.00 | +488.24% | Reiterates | a day ago |
Galectin Therapeutics IncGALT | 2 | Buy | $11.00 | +169.61% | Maintains | 14 days ago |
60 Degrees Pharmaceuticals IncSXTP | 1 | Buy | $6.00 | +1,085.77% | Assumes | 2 months ago |
Acurx Pharmaceuticals IncACXP | 2 | Buy | $31.00 | +1,083.21% | Reiterates | 3 months ago |
Fibrogen IncFGEN | 2 | Buy | $43.00 | +394.25% | Reiterates | 3 months ago |
Gyre Therapeutics IncGYRE | 1 | Buy | $18.00 | +156.41% | Initiates Coverage On | 4 months ago |
Phio Pharmaceuticals CorpPHIO | 1 | Buy | $14.00 | +1,272.55% | Reiterates | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.